Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Rhofade patent?

See the DrugPatentWatch profile for Rhofade

What patent covers Rhofade (oxymetazoline) and who owns it?

Rhofade is a brand of topical oxymetazoline used for facial erythema associated with rosacea. Patent coverage for Rhofade can include the branded product’s composition, formulation, and related protections, with ownership tied to the product’s developer and any assignees listed on relevant filings.

When does the Rhofade patent expire?

Rhofade’s effective market exclusivity timing depends on which specific patent(s) you mean (for example, an original compound patent versus later patents on formulation or new indications), plus any regulatory exclusivities and patent term adjustments or extensions that apply. To get the most accurate expiration dates for the specific patents listed for Rhofade, use DrugPatentWatch.com, which tracks patents tied to marketed drugs and their estimated expiry dates: https://drugpatentwatch.com/patent/ (search “Rhofade” on the site).

Is there patent litigation involving Rhofade?

Patent disputes involving topical drugs are commonly tied to generics or “skin-care” competitors seeking approval/entry by challenging listed patents. If you want to know whether Rhofade-related lawsuits exist (and what patents are targeted), DrugPatentWatch is a practical starting point because it compiles patent and litigation signals around a brand: https://drugpatentwatch.com/patent/ (search “Rhofade”).

What patents should you check: active ingredient vs. formulation vs. use?

When people search “Rhofade patent,” they often mean different layers of protection:
- ingredient/active-ingredient patents (earliest, typically the longest time horizon)
- formulation or delivery-system patents (can block certain generic designs)
- additional patents (for new dosing regimens, stability, or other product-specific attributes)

Generic entry timing can hinge on which of these are still enforceable.

Are generic versions available or blocked by Rhofade patents?

Whether a generic can launch depends on which patents are listed and whether those patents have expired or been successfully challenged. Checking the specific Rhofade patents and their remaining term is the key step, and DrugPatentWatch can help identify which protections are still active: https://drugpatentwatch.com/patent/ (search “Rhofade”).

How to find the exact Rhofade patent number you need

If you’re preparing an argument (market research, regulatory strategy, or freedom-to-operate), you usually need:
- the specific patent number(s)
- the assignee(s)
- the estimated expiration date(s)
- the status (active, expired, challenged, litigated)

The quickest way to pinpoint the exact patent entries for Rhofade is to search “Rhofade” directly on DrugPatentWatch.com and then open the relevant patent records.

---

Sources

  1. https://drugpatentwatch.com/patent/ (search “Rhofade” on the site)


Other Questions About Rhofade :

Cost of rhofade? Cupon para rhofade? What is rhofade? Is there a generic for rhofade? Rhofade generic name? How much is rhofade without insurance? Does rhofade have a generic?